Inflammation, Gut Microbiota, and Metabolomic Shifts in Colorectal Cancer: Insights from Human and Mouse Models
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011189 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chengcong Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot 010018, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gastrointestinal Microbiome, Inflammation, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inner Mongolia Autonomous Region Key R&D Plan Project, Inner Mongolia Autonomous Region Higher Education Institutions Innovation Team Development Plan, Inner Mongolia Autonomous Region Key R&D Plan Project.
Abstract (Originalsprache)
Colorectal cancer (CRC) arises from aberrant mutations in colorectal cells, frequently linked to chronic inflammation. This study integrated human gut metagenome analysis with an azoxymethane and dextran sulfate sodium-induced CRC mouse model to investigate the dynamics of inflammation, gut microbiota, and metabolomic profiles throughout tumorigenesis. The analysis of stool metagenome data from 30 healthy individuals and 40 CRC patients disclosed a significant escalation in both gut microbiota diversity and abundance in CRC patients compared to healthy individuals (p < 0.05). Marked structural disparities were identified between the gut microbiota of healthy individuals and those with CRC (p < 0.05), characterized by elevated levels of clostridia and diminished bifidobacteria in CRC patients (p < 0.05). In the mouse model, CRC mice exhibited distinct gut microbiota structures and metabolite signatures at early and advanced tumor stages, with subtle variations noted during the intermediate phase. Additionally, inflammatory marker levels increased progressively during tumor development in CRC mice, in contrast to their stable levels in healthy counterparts. These findings suggest that persistent inflammation might precipitate gut dysbiosis and altered microbial metabolism. Collectively, this study provides insights into the interplay between inflammation, gut microbiota, and metabolite changes during CRC progression, offering potential biomarkers for diagnosis. While further validation with larger cohorts is warranted, the data obtained support the development of CRC prevention and diagnosis strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot 010018, China.
- Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Hohhot 010018, China.
- Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot 010018, China.
Förderung
- Inner Mongolia Autonomous Region Key R&D Plan Project
- Inner Mongolia Autonomous Region Higher Education Institutions Innovation Team Development Plan
- Inner Mongolia Autonomous Region Key R&D Plan Project
- Central Guidance on Local Science and Technology Development Fund of Inner Monglian
Zitieren
APA
Yang, C., Wusigale, You, L., Li, X., Kwok, L. Y., & Chen, Y. (2024). Inflammation, Gut Microbiota, and Metabolomic Shifts in Colorectal Cancer: Insights from Human and Mouse Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011189
Vancouver
Yang C, Wusigale, You L, Li X, Kwok LY, Chen Y. Inflammation, Gut Microbiota, and Metabolomic Shifts in Colorectal Cancer: Insights from Human and Mouse Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011189
BibTeX
@article{Yang2024,
author = {Yang, Chengcong and Wusigale and You, Lijun and Li, Xiang and Kwok, Lai-Yu and Chen, Yongfu},
title = {Inflammation, Gut Microbiota, and Metabolomic Shifts in Colorectal Cancer: Insights from Human and Mouse Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011189}
}
EUVIMED